Drugplain

Glycerol phenylbutyrate 1.1 g/mL

Glycerol phenylbutyrate · LIQUID · Novadoz Pharmaceuticals LLC

No Recall History
Plain English

Glycerol phenylbutyrate is a liquid medication taken by mouth that helps manage urea cycle disorders by reducing ammonia levels in the body. It works by providing an alternative pathway for the body to eliminate excess nitrogen.

Key Facts

Brand Name
Glycerol phenylbutyrate
Generic Name
Glycerol phenylbutyrate
NDC Code (Product)
72205-331
Manufacturer
Novadoz Pharmaceuticals LLC
Strength
1.1 g/mL
Dosage Form
LIQUID
Route
ORAL
Marketing Status
Application #
ANDA219540
Marketing Start
04/15/2026

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

hyperammonaemic crisis5 reports
ammonia increased3 reports
drug ineffective3 reports
hyperammonaemia3 reports
hyperammonaemic encephalopathy3 reports
myelosuppression3 reports
condition aggravated2 reports
feeling abnormal2 reports
nausea2 reports
neutropenia2 reports

Frequently Asked Questions

What is Glycerol phenylbutyrate used for?

Glycerol phenylbutyrate is a liquid medication taken by mouth that helps manage urea cycle disorders by reducing ammonia levels in the body. It works by providing an alternative pathway for the body to eliminate excess nitrogen.

Is Glycerol phenylbutyrate a controlled substance?

Glycerol phenylbutyrate is not classified as a controlled substance by the DEA.

What is the generic name for Glycerol phenylbutyrate?

The generic name for Glycerol phenylbutyrate is Glycerol phenylbutyrate. There are 5 other brand versions of Glycerol phenylbutyrate.

What is the NDC code for Glycerol phenylbutyrate 1.1 g/mL?

The NDC (National Drug Code) for Glycerol phenylbutyrate 1.1 g/mL is 72205-331, listed by Novadoz Pharmaceuticals LLC.

Product NDC

72205-331

Package NDC

72205-331-57

Other Glycerol phenylbutyrate Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)